MedTrace Logo

Serious Gaming for Chemotherapy-induced Nausea and Vomiting

NCT05838638 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 610

Last updated 2026-05-01

No results posted yet for this study

Summary

The purpose of this study is to examine the effectiveness of a technology-based intervention for managing nausea and vomiting in older adults with cancer. Participants will be randomized to either an intervention or control group. Outcomes such as symptom severity, quality of life, and resource use will be examined.

Conditions

  • Neoplasms
  • Chemotherapy-induced Nausea and Vomiting

Interventions

BEHAVIORAL

eSSET-CINV

Participants in the intervention group will be asked to play the serious game on an iPad at their first chemotherapy treatment visit. The control group will be able to play at time 6.

Sponsors & Collaborators

  • Orlando Health, Inc.

    collaborator OTHER

  • University of Miami

    collaborator OTHER

  • National Institute of Nursing Research (NINR)

    collaborator NIH

  • University of Central Florida

    lead OTHER

Principal Investigators

  • Victoria Loerzel, PhD · University of Central Florida

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-09
Primary Completion
2027-06-30
Completion
2027-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05838638 on ClinicalTrials.gov